Aratana Therapeutics
Pharmaceutical Manufacturing • 
Leawood, Kansas, United States • 11-20 Employees
Company overview
| Headquarters | 11400 Tomahawk Creek Parkway, Suite 340, Leawood, KS 66211, US |
| Phone number | +18447447389 |
| Website | |
| NAICS | 3254 |
| Keywords | Biotechnology, Pharmaceuticals, Research And Development, Veterinarian, Veterinary Medicine, Companion Animal, Pet Therapeutics |
| Founded | 2010 |
| Employees | 11-20 |
| Socials |
Key Contact at Aratana Therapeutics
Graig Mcbride
Director Research & Development
Aratana Therapeutics Email Formats
Aratana Therapeutics uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 42.1% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name}@company.com | john.doe@company.com | 42.1% |
{first name}@company.com | john@company.com | 25.3% |
{first name initial}{last name}@company.com | {first name initial}doe@company.com | 14.8% |
{first name}{last name}@company.com | johndoe@company.com | 10.2% |
{last name}@company.com | doe@company.com | 7.6% |
About Aratana Therapeutics
Aratana Therapeutics, Inc. (Nasdaq: PETX) is a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats. Our mission is to successfully develop and deliver best-in-class therapeutics, provide comprehensive service to veterinarians and serve as a collaborator of choice for human and animal health companies. We believe our therapeutics are highly differentiated, resolve recognizable needs in compelling markets and have therapeutic profiles superior to the standard of care. Our FDA-approved and commercially available therapeutics include: - A prostaglandin receptor antagonist that specifically targets the EP4 receptor to target osteoarthritis pain and inflammation in dogs - A selective ghrelin receptor agonist that mimics ghrelin, the naturally-occurring “hunger hormone,” to stimulate appetite in dogs - A long-acting, local anesthetic that provides up to 72 hours post-operative pain relief following certain surgeries in dogs and cats
Aratana Therapeutics revenue & valuation
| Annual revenue | $38,800,000 |
| Revenue per employee | $2,582,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $124,000,000 |
| Total funding | $11,700,000 |
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Aratana Therapeutics has 10 employees across 6 departments.
Departments
Number of employees
Italy
Australia
Spain
New Zealand
Frequently asked questions
4.8
40,000 users
